共 67 条
[1]
ACCOLLA RS, 1981, J IMMUNOL, V127, P2438
[6]
BLACKBURN R, 1991, ADV EXP MED BIOL, V303, P63
[8]
Phase II trial of Remitogen™ (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma
[J].
CLINICAL LYMPHOMA,
2001, 2 (03)
:188-190

